Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-27

Clinical Trial Update: An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections [Phase 3]

View source ↗

Summary

Phase 3 trial comparing flomoxef with cefepime for urinary tract infections was terminated and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefepime (cefepime)
  • Flomoxef (flomoxef)

Snippet

Sponsor: Takeda | Conditions: Urinary Tract Infection | Phase 3 | Status: TERMINATED | Results posted: 2017-10-27